Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
17.57B | 18.41B | 23.00M | 16.32B | 15.13B | Gross Profit |
17.57B | 19.21B | 23.00M | 16.32B | 15.13B | EBIT |
17.57B | 11.05B | 10.52B | 6.80B | 1.16B | EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
4.42B | 5.46B | 5.46B | 5.78B | 1.32B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
62.68B | 139.41B | 91.63B | 76.57B | 73.56B | Total Assets |
906.70B | 881.45B | 877.83B | 886.52B | 871.27B | Total Debt |
80.92B | 93.67B | 84.55B | 84.66B | 101.66B | Net Debt |
18.24B | 14.65B | -7.08B | 8.09B | 28.10B | Total Liabilities |
860.81B | 834.09B | 830.31B | 84.66B | 101.66B | Stockholders Equity |
45.72B | 47.16B | 47.28B | 52.92B | 49.18B |
Cash Flow | Free Cash Flow | |||
-8.76B | 1.35B | 18.16B | 3.39B | 24.27B | Operating Cash Flow |
-4.39B | 6.81B | 22.01B | 6.62B | 27.17B | Investing Cash Flow |
-7.69B | -9.82B | 510.00M | -2.54B | -4.00B | Financing Cash Flow |
-5.93B | -8.46B | -6.61B | -3.23B | -5.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $208.45B | 9.68 | 12.96% | 5.02% | 6.79% | 8.57% | |
81 Outperform | $53.65B | 8.53 | 8.78% | 2.62% | 8.58% | 35.39% | |
77 Outperform | $94.96B | 7.65 | 11.61% | 2.36% | 11.61% | 24.35% | |
76 Outperform | $55.31B | 11.89 | 9.67% | 3.96% | 36.29% | -19.79% | |
64 Neutral | $14.34B | 10.61 | 9.28% | 4.07% | 18.04% | -9.54% |